Adrienne Graves L.'s Insider Trades & SAST Disclosures
Adrienne Graves L.'s most recent trade in Opus Genetics Inc. was a trade of 172,874 Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 22, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Adrienne Graves L..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 172,874 | 172,874 | - | - | Stock Option (right to buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 36,000 (0%) | 0% | 0 | Common Stock | |
| Harrow Health Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 8,347 | 8,347 | - | - | RSU | |
| Harrow Health Inc | Adrienne Graves L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 3,119 | 3,119 | - | - | RSU | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 72,000 | 72,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Adrienne L. Graves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2023 | 24,000 | 24,000 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges